Ernexa Therapeutics Inc. Proceeds from Common Stock Issued
Ernexa Therapeutics Inc. (ERNA) reported Proceeds from Common Stock Issued of $10.48 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2026-08-06
- Ernexa Therapeutics Inc. proceeds from issuance of common stock for the quarter ending 2026-03-31 was $10.48M.
- Ernexa Therapeutics Inc. proceeds from issuance of common stock for the quarter ending 2025-12-31 was $0.00.
- Ernexa Therapeutics Inc. proceeds from issuance of common stock for the quarter ending 2025-09-30 was $0.00.
- Ernexa Therapeutics Inc. proceeds from issuance of common stock for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- Ernexa Therapeutics Inc. proceeds from issuance of common stock for fiscal 2025 was $4.93M, a 333.51% increase from fiscal 2024.
- Ernexa Therapeutics Inc. proceeds from issuance of common stock for fiscal 2024 was $1.14M.
- Ernexa Therapeutics Inc. proceeds from issuance of common stock for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Ernexa Therapeutics Inc. proceeds from issuance of common stock for fiscal 2022 was $19.71M.
| Period end | Proceeds from Issuance of Common Stock 1 month | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 6 month as first filed | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 9 month as first filed | Proceeds from Issuance of Common Stock 12 month | Proceeds from Issuance of Common Stock 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $10.48M 10-Q · filed 2026-05-11 | $10.48M derived: sum of 2 quarters · filed 2026-05-11 | $10.48M derived: sum of 3 quarters · filed 2026-05-11 | |||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $0.00 derived: sum of 2 quarters · filed 2026-03-13 | $4.93M 10-K · filed 2026-03-13 | |||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $4.93M 10-Q · filed 2025-11-07 | ||||||
| 2025-06-30 | $4.93M 10-Q · filed 2026-08-06 | |||||||
| 2024-12-31 | $1.14M 10-K · filed 2026-03-13 | |||||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $0.00 derived: sum of 2 quarters · filed 2024-03-14 | $0.00 derived: sum of 3 quarters · filed 2024-03-14 | $0.00 10-K · filed 2024-03-14 | ||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | $7.71M derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $0.00 10-Q · filed 2023-08-11 | $7.71M derived: sum of 3 quarters · filed 2024-03-14 | $7.71M derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-11 | $7.71M derived: sum of 2 quarters · filed 2024-03-14 | $7.71M derived: sum of 3 quarters · filed 2024-03-14 | $7.71M derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2022-12-31 | $7.71M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $7.71M derived: sum of 2 quarters · filed 2024-03-14 | $7.71M derived: sum of 3 quarters · filed 2024-03-14 | $19.71M 10-K · filed 2024-03-14 | ||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $11.99M 10-Q · filed 2023-11-13 | $11.99M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $11.99M 10-Q · filed 2023-08-11 | $11.99M derived: sum of 3 quarters · filed 2023-08-11 | $11.99M derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | $11.99M 10-Q · filed 2023-05-11 | $11.99M derived: sum of 2 quarters · filed 2023-05-11 | $11.99M derived: sum of 3 quarters · filed 2023-05-11 | $11.99M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $0.00 derived: sum of 2 quarters · filed 2023-03-20 | $0.00 derived: sum of 3 quarters · filed 2023-03-20 | $0.00 10-K · filed 2023-03-20 | $52.02M 10-K · filed 2022-04-15 | |||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | $52.03M 10-Q · filed 2021-11-12 | $0.00 derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $0.00 10-Q · filed 2022-08-11 | $48.52M 10-Q · filed 2021-08-13 | $0.00 derived: sum of 3 quarters · filed 2022-08-11 | $0.00 derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | $0.00 10-Q · filed 2022-07-01 | $0.00 derived: sum of 2 quarters · filed 2022-07-01 | $0.00 derived: sum of 3 quarters · filed 2022-07-01 | |||||
| 2020-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-01 | $0.00 derived: sum of 2 quarters · filed 2022-07-01 | $0.00 10-K/A · filed 2022-07-01 | |||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 10-Q · filed 2021-11-12 | ||||||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-13 | |||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | -$6.00K derived: sum of 2 quarters · filed 2019-03-22 | $1.38M 10-K · filed 2019-03-22 | |||||
| 2018-09-30 | -$6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $1.38M 10-Q · filed 2018-11-09 | ||||||
| 2018-06-30 | $1.38M 10-Q · filed 2018-08-06 | |||||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $0.00 derived: sum of 2 quarters · filed 2019-03-22 | $219.00K derived: sum of 3 quarters · filed 2019-03-22 | $1.77M 10-K · filed 2019-03-22 | ||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $219.00K derived: sum of 2 quarters · filed 2018-11-09 | $1.77M 10-Q · filed 2018-11-09 | |||||
| 2017-06-30 | $219.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $1.77M 10-Q · filed 2018-08-06 | ||||||
| 2017-03-31 | $1.55M 10-Q · filed 2018-05-11 | |||||||
| 2016-12-31 | $2.69M 10-K · filed 2018-03-09 | |||||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $0.00 10-Q · filed 2015-11-09 | ||||||
| 2015-06-30 | $0.00 10-Q · filed 2015-08-10 | |||||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $0.00 derived: sum of 2 quarters · filed 2016-03-15 | $6.37M 10-K · filed 2016-03-15 | |||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $6.37M 10-Q · filed 2015-11-09 | ||||||
| 2014-06-30 | $6.37M 10-Q · filed 2015-08-10 | |||||||
| 2014-04-30 | $7.02M 10-K · filed 2016-03-15 | |||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $0.00 derived: sum of 2 quarters · filed 2015-03-27 | $0.00 10-K · filed 2015-03-27 | |||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $0.00 10-Q · filed 2014-11-07 | ||||||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-14 | |||||||
| 2012-09-30 | $2.50M 10-Q · filed 2012-11-09 | |||||||
| 2012-02-29 | $2.50M 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |